ATE109343T1 - Dosierungseinheit zur transdermalen absorbierung für estradiol und sonstige estrogene steroide. - Google Patents

Dosierungseinheit zur transdermalen absorbierung für estradiol und sonstige estrogene steroide.

Info

Publication number
ATE109343T1
ATE109343T1 AT87903790T AT87903790T ATE109343T1 AT E109343 T1 ATE109343 T1 AT E109343T1 AT 87903790 T AT87903790 T AT 87903790T AT 87903790 T AT87903790 T AT 87903790T AT E109343 T1 ATE109343 T1 AT E109343T1
Authority
AT
Austria
Prior art keywords
estradiol
transdermal absorption
another
dosing unit
estrogenic
Prior art date
Application number
AT87903790T
Other languages
English (en)
Inventor
Yie W Chien
Chia-Shun Lee
Kirti H Valia
Te-Yen Chien
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Application granted granted Critical
Publication of ATE109343T1 publication Critical patent/ATE109343T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AT87903790T 1986-05-30 1987-05-29 Dosierungseinheit zur transdermalen absorbierung für estradiol und sonstige estrogene steroide. ATE109343T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/868,709 US4883669A (en) 1985-02-25 1986-05-30 Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration

Publications (1)

Publication Number Publication Date
ATE109343T1 true ATE109343T1 (de) 1994-08-15

Family

ID=25352181

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87903790T ATE109343T1 (de) 1986-05-30 1987-05-29 Dosierungseinheit zur transdermalen absorbierung für estradiol und sonstige estrogene steroide.

Country Status (11)

Country Link
US (1) US4883669A (de)
EP (1) EP0269696B1 (de)
JP (1) JP2579982B2 (de)
KR (1) KR960000553B1 (de)
AT (1) ATE109343T1 (de)
AU (2) AU7489587A (de)
CA (1) CA1300019C (de)
DE (1) DE3750327T2 (de)
DK (1) DK41988A (de)
FI (1) FI880409A0 (de)
WO (1) WO1987007138A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5019395A (en) * 1988-03-08 1991-05-28 Warner-Lambert Company Compositions with enhanced penetration
US4865920A (en) * 1988-09-20 1989-09-12 Dow Corning Corporation Hot-melt pressure sensitive adhesive article and method of making
KR900701242A (ko) * 1988-12-01 1990-12-01 스타이너 브이. 캔스타드 에스트라디올의 경피전달용 조성물
US4978532A (en) * 1989-08-11 1990-12-18 Pharmedic Co. Dosage form for administration of dehydroepiandrosterone
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
WO1991018572A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Device for transdermal administration of drugs
AU653771B2 (en) * 1991-01-03 1994-10-13 Alkermes Controlled Therapeutics, Inc. Stabilization of proteins by cationic biopolymers
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
US5300299A (en) * 1991-07-22 1994-04-05 Dow Corning Corporation Silicone pressure sensitive adhesive containing alkylmethylsiloxane wax and related methods and devices
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
FI962618A7 (fi) * 1993-12-27 1996-06-25 Akzo Nobel Nv Perkutaanisesti absorboituva valmiste
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
AU5971294A (en) * 1994-01-27 1995-08-15 Schering Aktiengesellschaft Agent, intended for transdermal administration, containing 14alpha,17alpha-ethanoestra-1,3,5(10)-triene-3,17beta -diol
AU702593B2 (en) 1994-09-14 1999-02-25 Minnesota Mining And Manufacturing Company Matrix for transdermal drug delivery
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
DK0836506T4 (da) * 1995-06-07 2012-01-30 Ortho Mcneil Pharm Inc Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
FR2749586B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Inc Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
DE19643959A1 (de) * 1996-10-31 1998-05-07 Lohmann Therapie Syst Lts Kleber, enthaltend Polymere mit einem sehr geringen Gehalt an Restmonomeren, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US6488940B2 (en) 1997-08-21 2002-12-03 Johnson & Johnson Consumer Companies, Inc. Use of 17-α-estradiol for the treatment of aged or sundamaged skin and/or skin atrophy
AU754680B2 (en) * 1997-08-21 2002-11-21 Johnson & Johnson Consumer Companies, Inc. Use of 17-alpha-estradiol for the treatment of aged or sundamaged skin and/or skin atrophy
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
US6692763B1 (en) * 1998-11-19 2004-02-17 The Regents Of The University Of California Methods for treating postmenopausal women using ultra-low doses of estrogen
DE19834007C1 (de) 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung
US6465004B1 (en) * 1999-06-05 2002-10-15 Noven Pharmaceuticals, Inc. Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
CA2374930C (en) * 1999-07-02 2008-08-05 Lts Lohmann Therapie-Systeme Ag Microreservoir system based on polysiloxanes and ambiphilic solvents
DE19958554C2 (de) * 1999-07-02 2002-06-13 Lohmann Therapie Syst Lts Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
US6221384B1 (en) 1999-11-05 2001-04-24 Anthony C. Pagedas Segmented transdermal dosage unit
US7384650B2 (en) 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
AU3104301A (en) 2000-01-20 2001-07-31 Noven Pharmaceuticals, Inc. Compositions and methods to effect the release profile in the transdermal administration of active agents
DE10157745A1 (de) * 2001-11-24 2003-06-26 Hf Arzneimittelforsch Gmbh Transdermales therapeutisches System zur Verabreichung von 17alpha-Estradiol
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US20050202073A1 (en) * 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US20130225845A1 (en) * 2010-11-04 2013-08-29 Lupin Limited Process for preparation of estradiol valerate and a novel crystalline form a of estradiol divalerate

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US4053580A (en) * 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
SU1243627A3 (ru) * 1979-12-05 1986-07-07 Дзе Кендалл Компани (Фирма) Гелеобразующа композици
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4336243A (en) * 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad
US4460372A (en) * 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4585452A (en) * 1983-04-12 1986-04-29 Key Pharmaceuticals, Inc. Transdermal systemic dosage forms
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US4693887A (en) * 1983-09-15 1987-09-15 The Kendall Company Microphase separated hydrogels for controlled release of bioactive materials
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
EP0186019B1 (de) * 1984-12-22 1993-10-06 Schwarz Pharma Ag Wirkstoffpflaster
DE3685895T2 (de) * 1985-02-25 1992-12-24 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
CA1288698C (en) * 1985-08-30 1991-09-10 Rutgers, The State University Of New Jersey Transdermal anti-anginal pharmaceutical dosage
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches

Also Published As

Publication number Publication date
DK41988D0 (da) 1988-01-28
JPH01501146A (ja) 1989-04-20
DE3750327T2 (de) 1994-12-08
CA1300019C (en) 1992-05-05
AU7526891A (en) 1991-09-12
EP0269696B1 (de) 1994-08-03
DE3750327D1 (de) 1994-09-08
FI880409A7 (fi) 1988-01-29
JP2579982B2 (ja) 1997-02-12
EP0269696A4 (de) 1990-02-06
EP0269696A1 (de) 1988-06-08
AU635182B2 (en) 1993-03-11
US4883669A (en) 1989-11-28
WO1987007138A1 (en) 1987-12-03
FI880409L (fi) 1988-01-29
AU7489587A (en) 1987-12-22
KR880701114A (ko) 1988-07-25
FI880409A0 (fi) 1988-01-29
KR960000553B1 (ko) 1996-01-09
DK41988A (da) 1988-01-28

Similar Documents

Publication Publication Date Title
DE3750327D1 (de) Dosierungseinheit zur transdermalen absorbierung für estradiol und sonstige estrogene steroide.
ES2074982T3 (es) Unidad de dosificacion transdermica de estrogeno/progestina, y estuche de control de la fertilidad que comprende dicha unidad de dosificacion.
DE68926122D1 (de) Transdermale estrogen/progestin-dosiereinheit und system.
KR920700602A (ko) 폐경기후의 증후군을 치료하기 위한 경피 흡수 투여 단위 및 투여 방법
ATE119380T1 (de) Dosiereinheit für die perkutane absorption analgetischer oder antagonistischer narkotika.
EP0836506A4 (de) Transdermales pflaster und verfahren zur verabreichung von 17-deacetyl norgestimat alleine oder in kombination mit einem östrogen
KR960703545A (ko) 테스토스테론의 공급을 위한 피부패치 및 방법(skin patches and methods for providing testosterone)
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
KR900015761A (ko) 경피성 단일체 시스템
ATE109357T1 (de) Transdermales estradiol als therapeutisches sytem.
DE69730988D1 (de) Neue formulierungen zur transdermale verabreichung von fluoxetinacetat und fluoxetinmaleat
ATE270554T1 (de) Kombination der progesteron und mifepristone für krebs-therapie
ES2001064A6 (es) Procedimiento para la obtencion de un sistema de suministro transdermico de una substancia vasoactiva.
YU49390A (sh) Postupak za izradu transdermalnog terapijskog sistema sa stupnjevitim otpuštanjem aktivne materije
BR9711812A (pt) EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade
AR003979A1 (es) Administracion transdermica de vorozol.
AU6229086A (en) Novel transdermal anti-anginal pharmaceutical dosage unit and process for its administration
DK131586A (da) Transdermalt, antiallergisk, farmaceutisk praeparat
KR900700142A (ko) 에스트로겐/프로게스틴 경피 투여 단위, 시스템 및 방법
Bishop Male Sex Hormones
BR9912688A (pt) Emplastro contendo estradiol para aplicaçãotransdérmica de hormÈnios
DE69637416D1 (de) Topische anwendung von opioiden, wie morphin, zur linderung von juckreiz und hautkrankheiten sowie hautreizungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee